Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-153-9 | CAS number: 10045-95-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test item showed toxicity (IC30 values of 46 μM and 51 μM and IC50 values of 1352 μM and 1101 μM in experiment 1 and 2, respectively). No biologically relevant induction of the luciferase activity (no EC1.5 value) was measured at any of the test concentrations in both experiments. The maximum luciferase activity induction (Imax) was 1.13-fold and 1.10-fold in experiment 1 and 2 respectively. The test item is classified as negative in the KeratinoSensTM assay since negative results (<1.5-fold induction) were observed at test concentrations up to 2000 μM.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 March 2020 to 2 May 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- activation of keratinocytes
- Justification for non-LLNA method:
- In the interest of sound science and animal welfare, a sequential testing strategy is recommended to minimize the need of in vivo testing. One of the validated in vitro skin sensitization tests is the KeratinoSensTM assay, which is recommended in international guidelines (e.g. OECD 442D).
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch number of test material: NDNC-191202-BZ
- Expiration date of the lot/batch: 12 December 2020
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature
- Stability under storage conditions: Assumed to be stable
- Stability under test conditions: Assumed to be stable
- Solubility and stability of the test substance in the solvent/dispersant/vehicle/test medium: Soluble in DMSO
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: stock solution prepared in DMSO or Milli-Q. Two-fold dilution series prepared in DMSO or Milli-Q.
- Final dilution of a dissolved solid, stock liquid or gel: Final dilution carried out in culture medium
- Details on the study design:
- Skin sensitisation (In vitro test system) - Details on study design:
Cells will be subcultured upon reaching 80-90% confluency. To maintain the integrity of the response, the cells will be grown for more than one passage from the frozen stock, and will not be cultured for more than 25 passages from the frozen stock.
For testing, cells should be 80-90% confluent, and care should be taken to ensure that cells are grown to full confluence. One day prior to testing cells are harvested, and distributed into 96-well plates (10,000 cells/well) in basic medium. One plate is used for the luciferase activity measurements, and one parallel replicate used for the MTT cell viability assay. The cells are incubated overnight.
The medium is removed and replaced with fresh culture medium (150 μl culture medium containing serum but without Geneticin) to which 50 µL of the 25 fold diluted test chemical and control substances are added. At least one well per plate should be left empty (no cells and no treatment) to assess background values. The treated plates are then incubated for
48 hours ± 1 h at 37±1.0oC in the presence of 5% CO2.
200 µL of the Steady-Glo Luciferase substrate solution (prior to addition 1:1 mixed with exposure medium) is added to each well. The plates are then shaken for at least 5 minutes at room temperature. Plates with the cell lysates are then placed in the luminometer to assess the quantity of luciferase
For the KeratinoSensTM cell viability assay, medium is replaced after the 48 hour exposure time with fresh medium containing MTTand cells incubated for 3 - 4 hours at 37°C ± 1.0°C in the presence of 5% CO2. The MTT medium is then removed and cells are lysed overnight by adding 10% SDS solution to each well. After shaking, the absorption is measured at 570 nm - Positive control results:
- The luciferase activity induction obtained with the positive control, Ethylene dimethacrylate glycol, was statistically significant above the threshold of 1.5-fold in at least one concentration.
The EC1.5 of the positive control was within two standard deviations of the historical mean (114 μM and 52 μM in experiment 1 and 2, respectively). A dose response was observed and the induction at 250 μM was higher than 2-fold in the second experiment (2.88-fold). Although, the induction at 250 μM was not higher than 2-fold in the first experiment (1.99-fold), a clear dose-response was observed with increasing luciferase activity induction at increasing concentrations, and therefore the experiment is considered acceptable. - Key result
- Run / experiment:
- other: Expt 1
- Parameter:
- other: Imax
- Value:
- 1.13 µM
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Run / experiment:
- other: Expt 2
- Parameter:
- other: Imax
- Value:
- 1.1 µM
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Run / experiment:
- other: Expt 1
- Parameter:
- other: IC30
- Value:
- 46 µM
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Run / experiment:
- other: Expt 1
- Parameter:
- other: IC50
- Value:
- 1 352 µM
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Run / experiment:
- other: Excpt 2
- Parameter:
- other: IC30
- Value:
- 51 µM
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Run / experiment:
- other: Expt 2
- Parameter:
- other: IC50
- Value:
- 1 101 µM
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Acceptance criteria met for variability between replicate measurements: Yes
- Range of historical values if different from the ones specified in the test guideline: Yes - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item showed toxicity (IC30 values of 46 μM and 51 μM and IC50 values of 1352 μM and 1101 μM in experiment 1 and 2, respectively). No biologically relevant induction of the luciferase activity (no EC1.5 value) was measured at any of the test concentrations in both experiments. The maximum luciferase activity induction (Imax) was 1.13-fold and 1.10-fold in experiment 1 and 2 respectively. The test item is classified as negative in the KeratinoSensTM assay since negative results (<1.5-fold induction) were observed at test concentrations up to 2000 μM.
- Executive summary:
The objective of this study was to evaluate the ability of Neodymium Trinitrate to activate the antioxidant/electrophile responsive element (ARE)-dependent pathway in the KeratinoSens assay.
The study procedures described in this report were based on the most recent OECD guideline. Batch NDNC-191202-BZ of the test item was a purple to blue-pink solid. The test item was dissolved in dimethyl sulfoxide at 200 mM. From this stock 11 spike solutions in DMSO were prepared. The stock and spike solutions were diluted 100-fold in the assay resulting in test concentrations of 0.98–2000 μM (2-fold dilution series). The highest test concentration was the highest dose required in the current guideline. Precipitate was observed at test concentrations of 250 μM and upwards at the start and end of the incubation period in both experiments. Two independent experiments were performed.
Both tests passed the acceptance criteria:The luciferase activity induction obtained with the positive control, Ethylene dimethacrylate glycol, was statistically significant above the threshold of 1.5-fold in at least one concentration; The EC1.5of the positive control was within two standard deviations of the historical mean (114 μM and 52 μM in experiment 1 and 2, respectively). A dose response was observed and the induction at 250 μM was higher than 2-fold in the second experiment (2.88-fold). Although, the induction at 250μM was not higher than 2-fold in the first experiment (1.99-fold), a clear dose-response was observed with increasing luciferase activity induction at increasing concentrations, and therefore the experiment is considered acceptable; Finally, the average coefficient of variation of the luminescence reading for the vehicle (negative) control DMSO was below 20% (10% and 9.1% in experiment 1 and 2, respectively).
Overall it is concluded that the test conditions were adequate and that the test system functioned properly. The test item showed toxicity (IC30values of 46 μM and 51 μM and IC50values of 1352 μM and 1101 μM in experiment 1 and 2, respectively). No biologically relevant induction of the luciferase activity (no EC1.5value) was measured at any of the test concentrations in both experiments. The maximum luciferase activity induction (Imax) was 1.13-fold and 1.10-fold in experiment 1 and 2 respectively. The test item is classified as negative in the KeratinoSensTMassay since negative results (<1.5-fold induction) were observed at test concentrations up to 2000 μM.
In conclusion, Neodymium Trinitrate is classified as negative (no activation of the antioxidant/electrophile responsive element (ARE)-dependent pathway in keratinocytes)
under the experimental conditions described in this report.
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 luciferase KeratinoSens™ test method)
- Principles of method if other than guideline:
- The objective of this study was to generate a weight of evidence assessment on the endpointof skin sensitization for Neodymium trinitrate. A KeratinoSensTM assay was performed in accordance with Section 8.3 of Annex VII of Regulation (EC) No 1907/2006 as amended in Commission Regulation (EU) 2016/1688 of 20 September 2016 and the strategy presented in ECHA Guidance on information requirements and chemical safety assessment Chapter R.7a. Only the KeratinoSensTM assay, assessing key event (KE) 2 of the skin sensitization adverse outcome pathway (AOP), could be performed. Testing for KE 1 of the skin sensitization AOP with the in chemico Direct Peptide Reactivity Assay (DPRA) assay was not applicable as Neodymium trinitrate is a metal compound and testing for KE 3 with the U-SENSTM assay was considered not applicable due to the cytotoxic properties of Neodymium trinitrate. The KeratinoSensTM assay was negative as no luciferase induction was observed after keratinocytes were exposed to Neodymium trinitrate. Additionally, the publicly available data on the metal Neodymium and its analogue salts, and the nitrate salts indicate that it is unlikely that Neodymium trinitrate is a skin sensitizer. Based on these considerations, sufficient evidence has been provided to conclude that Neodymium trinitrate is unlikely to be a skin sensitizer and does not need to be classified for skin sensitization according to Regulation (EC) No 1272/2008 and related amendments.
- GLP compliance:
- yes
- Type of study:
- ARE-Nrf2 luciferase LuSens test method
- Specific details on test material used for the study:
- Identification: Neodymium trinitrate
IUPAC name Neodymium(3+) trinitrate
CAS number 10045-95-1
EC number 233-153-9
Molecular formula Nd(NO3)3
Purity ≥ 99.9%
Molecular weight 438.35 g/mol - Details of test system:
- Lusens transgenic cell line [442D]
- Group:
- test chemical
- Run / experiment:
- run/experiment 1
- Remarks on result:
- no indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- An in vitro study showed this substance to be non-sensitising
- Executive summary:
The objective of this study was to generate a weight of evidence assessment on the endpoint of skin sensitization for Neodymium trinitrate.
A KeratinoSensTM assay was performed in accordance with Section 8.3 of Annex VII of Regulation (EC) No 1907/2006 as amended in Commission Regulation (EU) 2016/1688 of 20 September 2016 and the strategy presented in ECHA Guidance on information requirements and chemical safety assessment Chapter R.7a.
Only the KeratinoSensTM assay, assessing key event (KE) 2 of the skin sensitization adverse outcome pathway (AOP), could be performed. Testing for KE 1 of the skin sensitization AOP with the in chemico Direct Peptide Reactivity Assay (DPRA) assay was not applicable as Neodymium trinitrate is a metal compound and testing for KE 3 with the U-SENSTM assay was considered not applicable due to the cytotoxic properties of Neodymium trinitrate.
The KeratinoSensTM assay was negative as no luciferase induction was observed after keratinocytes were exposed to Neodymium trinitrate. Additionally, the publicly available data on the metal Neodymium and its analogue salts, and the nitrate salts indicate that it is unlikely that Neodymium trinitrate is a skin sensitizer. Based on these considerations, sufficient evidence has been provided to conclude that Neodymium trinitrate is unlikely to be a skin sensitizer and does not need to be classified for skin sensitization according to Regulation (EC) No 1272/2008 and related amendments.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Two in vitro studies on luciferase activity resuted in negative results. Therefore this substance is not classified as a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.